A study in The New England Journal of Medicine shows omalizumab increases allergen tolerance in individuals with multiple food allergies, offering a promising standalone treatment option.
Study demonstrates efficacy of treat-to-target in early axial spondyloarthritis
Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in inducing drug-free remission, and EULAR – The European Alliance of Associations for Rheumatology –